Virtu Financial LLC Cyma Bay Therapeutics, Inc. Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $177,322 - $287,699	16,328 New	16,328 $243,000
Q2 2021 Sep 17, 2021	SELL	$3.94 - $4.92 $77,795 - $97,145	-19,745 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$4.23 - $6.55 $23,133 - $35,821	5,469 Added 38.31%	19,745 $90,000
Q4 2020 Feb 24, 2021	SELL	$5.73 - $9.03 $279,480 - $440,438	-48,775 Reduced 77.36%	14,276 $82,000
Q3 2020 Dec 11, 2020	BUY	$3.32 - $7.24 $209,329 - $456,489	63,051 New	63,051 $456,000
Q2 2020 Aug 07, 2020	SELL	$1.41 - $4.25 $47,385 - $142,829	-33,607 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.33 - $5.93 $44,697 - $199,289	33,607 New	33,607 $66,000
Q3 2019 Nov 20, 2019	SELL	$5.12 - $7.21 $122,839 - $172,982	-23,992 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.05 - $13.66 $145,151 - $327,730	23,992 New	23,992 $172,000
Q4 2018 Jan 16, 2019	SELL	$6.54 - $11.74 $129,406 - $232,299	-19,787 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.88 - $14.52 $215,282 - $287,307	19,787 New	19,787 $219,000
Q1 2018 May 14, 2018	SELL	$9.0 - $15.16 $222,615 - $374,982	-24,735 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.67 - $9.31 $68,255 - $82,849	8,899 Added 56.19%	24,735 $228,000
Q3 2017 Nov 15, 2017	BUY	$5.95 - $8.26 $94,224 - $130,805	15,836	15,836 $0

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.